posted on 2022-07-12, 09:22authored byMario Hiroyuki Hirata, Rosário Dominguez Crespo Hirata, Eric Batista Ferreira, Gisele Medeiros Bastos, Helena Strelow Thurow, Dalmo Antonio Ribeiro Moreira, Francisco Lotufo-Neto, Larissa Vilela Nascimento, Virginia Braga Cerutti
Table S1. Methylation in KCNE1, KCNH2 and SCN5A promoters of psychiatric patients (n=34), after 30 days of antidepressant treatment
Table S2. Methylation in KCNE1, KCNH2 and SCN5A promoters of psychiatric patients, after 30 days of treatment with fluoxetine or sertraline
Table S3. Correlation analysis between variation of methylation in KCNE1, KCNH2 and SCN5A promoters and electrocardiographic measurements of psychiatric patients on antidepressant treatment